Please find enclosed herewith Annual Secretarial Compliance Report for the financial year ended on March 31, 2026.
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mankind Pharma has filed its Annual Secretarial Compliance Report for the financial year ending March 31, 2026. The report, issued by practicing company secretaries Amit Gupta & Associates, confirms that the company maintained full compliance with all applicable SEBI regulations during the review period. The audit covered multiple regulations including SEBI LODR, ICDR, Takeover Regulations, SBEB, Insider Trading, and Depositories Regulations. No violations, deviations, or penalties were reported. The secretarial auditor verified secretarial standards, policy adoption, website disclosures, related party transactions, insider trading compliance, and document preservation. All compliance checkpoints returned positive status with no comments required.
This is a positive compliance filing with no red flags. The clean audit report indicates strong corporate governance practices and regulatory adherence, which should reinforce investor confidence in the company's governance standards.